Tag: opioids

  • How Drugs, Alcohol & Suicide Are Affecting The Average Lifespan

    How Drugs, Alcohol & Suicide Are Affecting The Average Lifespan

    A new CDC report has revealed some alarming changes in life expectancy trends.

    A new CDC report reveals that the average life expectancy in the United States is falling for the first time since 1993.

    Drugs, alcohol, and suicide are taking the lives of young Americans at rates so high that the U.S. life expectancy is being pushed down, according to the Centers for Disease Control and Prevention (CDC).

    The CDC’s National Center for Health Statistics (NCHS) has released a new federal report revealing that the U.S. life expectancy has dipped by about 0.3 years between 2014 and 2016.

    This breaks the pattern of steadily-rising life expectancy between 2006 and 2016, which saw growth from 77.8 years to 78.6 years. The causes for this drop in the general population, says the CDC, are rising drug overdose rates, suicide, liver disease, and Alzheimer’s.

    Drug deaths have been spiraling out of control over the past few years, killing 63,600 people in 2016.

    In 2016, liver disease surpassed HIV to take the dubious honor of being the sixth-highest cause of death for U.S. adults aged 25 to 44.

    Suicide has been on an upward trend for all demographics, including an alarming 9% increase in suicides by children from age 1 to 14 during the study period.

    While more men have died of overdose and suicide than women in the past, that gender gap is quickly closing. Drug overdose deaths jumped by about 19% for women aged 15 to 24 from 2014 to 2016. Suicide rates for young women have grown by a whopping 70% between 2010 and 2016.

    Deaths from Alzheimer’s disease have risen by 21%, and the CDC expects this number to grow larger as time goes on.

    However, the report wasn’t all bad news. Among Americans above the age of 65, deaths resulting from heart disease, cancer, and strokes have fallen.

    Drugs, alcohol, and suicide have been working to drive down life expectancy since 1993. While these increases may not seem like a big deal, Robert Anderson, chief of the mortality statistics branch at the National Center for Health Statistics, says we should be aware.

    “For any individual, that’s not a whole lot,” he told NPR. “But when you’re talking about it in terms of a population, you’re talking about a significant number of potential lives that aren’t being lived.”  

    View the original article at thefix.com

  • Backstreet Boy AJ McLean Inspired to Fight Addiction After Mac Miller’s Passing

    Backstreet Boy AJ McLean Inspired to Fight Addiction After Mac Miller’s Passing

    The pop star is throwing his weight behind a new line of home products made to help those struggling with addiction.

    The boy band singer is driven to stay sober and fight addiction with a new line of recovery products.

    Singer AJ McLean is leaning in to the fight against addiction following Mac Miller’s death. Having battled his own addictions in the past, McLean knows Miller’s struggles all too well.

    “I met him a couple of times at radio shows and he was a stand-up guy,” McLean told ET. “You would never know that he had a problem — but a lot of people had no idea that I had a problem. Addicts can hide it pretty well, so all my condolences go to his family and friends. He’s another one gone too soon.”

    McLean himself has two young daughters as motivation to stay sober, but Miller’s passing has given McLean a renewed vigor in combating addiction. He’s throwing his weight behind a new line of home products made to help those struggling with substance abuse, with a special focus on opioids.

    “With what recently happened with Mac Miller, people need to really understand how serious addiction is,” he remarked. “It’s a huge killer and you’ve just got to surround yourself with the right people, go to your meetings and get a sponsor. It’s a marathon, not a race. I’m getting involved with a pharmaceutical company that is going to be putting out some amazing products. One is an at-home opioid detox kit, non-narcotic because one of the biggest [causes of] deaths in the entire world right now is based on opioids.”

    In 2001, the Backstreet Boys stopped their Black & Blue tour to allow McLean to go to rehab for alcohol abuse treatment. He’s been open about his recovery process, fessing up to having relapsed on booze in the past during his recovery. To this day, McLean still does his best to attend at least five Alcoholics Anonymous meetings per week.

    These days McLean isn’t just staying sober for himself–he has his wife and two daughters, five-year-old Ava and one-year-old Lyric, to look after.

    “Having a family and looking my two girls in the eye every single night and every single morning —  they’re my lifeline,” he admitted. “They’re my everything. Them and my wife. So, I would never in a million years want to let them see me drunk or high or dead or in jail. I want to walk both my girls down the aisle … when they’re 35! As long as I can hold off on boys, I’m going to hold off on boys!”

    McLean’s schedule is pretty busy these days. Besides raising two daughters and backing a range of recover products, he’s also wrapping up work on a new Backstreet Boys album while also working on a solo country record.

    “I have been super busy trying to finish off my solo record, and this past week — I think, hopefully — we finished the Backstreet Boys record!” he told ET. “So, we can have it come out in October as planned, then tour around the world next year.”

    View the original article at thefix.com

  • Bringing Harm Reduction to Haywood County

    Bringing Harm Reduction to Haywood County

    The man in the camouflage shirt who emerges from the cabin is drawn and thin with circles under his eyes. He tenses at my presence, especially once Jeremy tells him I am there to write an article.

    It is a cloudy evening and mosquitoes patrol in full force as Nancy Bauman and I pick our way gingerly over trash-strewn ground, searching for syringes. Under a creekside bridge splashed with graffiti, a pair of neatly folded jeans, a plastic bag of food items, and a pair of shoes offer evidence of a homeless encampment.

    As we search, Nancy opens up about her life as a former injection drug user. She recounts how her only brother died of a heroin overdose shortly after returning from Vietnam. Her own struggle with addiction began through recreational drug use with homecoming soldiers, and years ago she lost her husband to hepatitis C infection. Drugs ruled much of her youth, but Nancy has spunk. She entertains me with tales of how she used to run an illegal syringe exchange program with two Catholic nuns in Los Angeles. 

    As I listen to Nancy, I am not putting much effort into the search for syringes. Truth be told, I feel guilty about picking through someone’s home and also for the assumption that a homeless person must also be an injection drug user. Under the bridge, Nancy and I find nothing but an overturned shopping cart, bits of trash, and a spoon. When the time comes to return to the health department, I feel relieved.

    Nancy and I drive back to the health department to rejoin the rest of the newly formed Substance Use Task Force of Haywood County, North Carolina. The community syringe pick-up event is the inaugural event for this group, which is comprised of public health employees, harm reduction advocates, law enforcement personnel and impacted citizens who hope to address the growing incidence of drug use in Haywood County. The dozen or so members are an eager bunch, well-intentioned but so far lacking clear direction on how to tackle such a complex problem. The group finds only two discarded syringes that evening; still, enthusiasm reigns.

    We are debriefed by members of the North Carolina Harm Reduction Coalition (NCHRC), which in spring 2018 hired three staff members for the area under a grant funded by the Aetna Foundation. Haywood County, and western North Carolina in general, is relatively new territory for NCHRC, which has more established programs in eastern and central parts of the state. In one sense, this is an advantage since advocates can draw on the experience of harm reduction programs in other counties. In another sense, it is a disadvantage. Few people in Haywood County have even heard of the term “harm reduction.” Appalachian residents, often tough and resistant to change, are not easily convinced and stigma against drug users runs deep. For the three new staff members, Gariann Yochym, Virgil Hayes, and Jeremy Sharp, the task of introducing harm reduction to Haywood County is both challenge and an opportunity.

    After the task force disbands, I join Jeremy Sharp to deliver supplies to participants of the mobile syringe exchange program he has helped establish. The clouds have rolled away and the sun is just beginning to set behind the backdrop of the Blue Ridge mountains. We drive past picturesque fields of hay bales and grain silos. The town is so pretty it almost looks painted. We pull up to a log cabin with a single tire swing swaying in the breeze under a tree.

    But the beauty ends here. The man in the camouflage shirt who emerges from the cabin is drawn and thin with circles under his eyes. He tenses at my presence, especially once Jeremy tells him I am there to write an article. As a peace offering, I put away my notebook.

    Jeremy delivers syringes and naloxone to the man and his wife, who emerges from the house. The wife gives a sobering account of her recent arrest for drug possession and the agony of opioid withdrawal she endured while in jail. She asks Jeremy for help getting Suboxone treatment for opioid use and he offers to connect her to his co-worker, Gariann, who can arrange an appointment. Jeremy is quirky but likeable, and the couple’s affection for him is clear.

    When we are back in the car and I have use of my notebook again, Jeremy admits that the stories of death and despair that he encounters on a daily basis can get to him. “I walk into people’s lives for 20 minutes to do an exchange and it can be overwhelming to hear even just a description of all the things they are going through,” he says. 

    “But,” he adds, brightening. “There is nothing like that first naloxone reversal.”

    The struggle to find hope in a grim situation is one that plagues other advocates as well. NCHRC’s Gariann Yochym, who connects Haywood County program participants to social services, lives this fight every day.

    At first glance, Gariann gives off strong hippie vibes. She hails from Asheville, North Carolina’s most notoriously liberal city, but was born and raised in the hills of West Virginia. She glides easily between country twang and the Queen’s English, comfortable in both worlds but fully belonging to neither. In that way, she is well-suited to the work in Haywood County, which necessitates a level of mastery in both progressive public health policy and rural resistance to change.

    Since arriving in Haywood County, Yochym has been laying foundational work to connect drug users to services that can help them improve their health. Introducing harm reduction to an often hostile political environment is not easy. When I first ask Yochym what she thinks of her job, she offers a sunny response: She loves to help people and make a difference. But with prodding, she admits that the work can be difficult.

    “Trying to build relationships and respect, sometimes I don’t know when I should bite my tongue or hold my ground,” she says. “It can be challenging to build new partnerships, but I think we all recognize the importance of working together to address these complex problems.”

    Haywood County is a microcosm of the challenges that harm reduction faces in general. Though the harm reduction movement has existed for decades, in many ways it is still the new kid in town, pushing back against centuries of punitive and abstinence-only approaches to drug use. Long a stronghold in northern states, harm reduction has more recently begun laying foundation in southern states, where politics can be antagonistic. For advocates, the constant dilemma of when to compromise and when to hold firm is exhausting. Bringing opposite sides together often means that neither gets what it wants, and advocates are criticized both for pushing too hard and not pushing hard enough.

    Virgil Hayes, who supervises the Haywood County staff and programs, also lives under this constant pressure. “Not everyone is where you would like them to be in terms of support for harm reduction,” he says as we talk over lunch at a small diner. “We need to understand that change is inevitable, but people need time to part ways with what they have always known.”

    Hayes seems to embrace the opportunity that Haywood County presents. “It’s been an adventure,” he says, smiling and shaking his head. I sense this is an understatement.

    Hayes sees his most important task as working to create a seat at the decision-making table for active drug users. Even in other parts of the state where harm reduction is more accepted, there is still a tendency for non-impacted professionals to speak on behalf of people who use drugs. However, while in other counties stakeholders may have already marked their territory and become resistant to new voices, Haywood County has the opportunity to invite those voices from the beginning. Hayes and his co-workers are actively working to do just that.

    Ultimately, the small team is game for the challenge of bringing harm reduction to Haywood County.

    “I am inspired by the way this community has come together and opened themselves up to our program,” says Yochym. “We have been welcomed with an incredible amount of hospitality and support from unlikely partners.”

    Hayes thinks that education will be key to getting people on board with harm reduction. “People’s hearts change when they realize everything is not what it seems,” he says. He hopes to draw attention and resources to rural counties, where the effects of drug use are often swept under the rug.

    “I want to show how this problem impacts all areas across race, gender, class and geography,” he says. “I want to pull the covers back and show the issue is just as bad here [as in cities] and to present solutions for what we are going to do to change it.”

    It is not easy being dropped into a geographically isolated area and launching a harm reduction program without much precedent or guidance, relying on intuition and experience to know when to compromise and when to stand your ground. It’s an even bigger challenge to fight centuries of stigma to bring active drug users to the decision-making table. But if anyone can do it, I think Haywood County can.

    View the original article at thefix.com

  • New York Times Op-Ed Slams "Incompetent" DEA Over Opioid Crisis

    New York Times Op-Ed Slams "Incompetent" DEA Over Opioid Crisis

    The writers of a scathing op-ed believe the federal agency “deserves much of the blame” for opioid-related deaths.

    A recent op-ed in the New York Times does not mince words in its critique of the U.S. Drug Enforcement Administration (DEA). “Because of its incompetence, the opioid crisis has gone from bad to worse. The solution: overhauling the agency, or even getting rid of it entirely,” write Leo Beletsky and Jeremiah Goulka in the Sept. 17 opinion piece.

    Rather than pointing to pharmaceutical drug makers or drug cartels, Beletsky and Goulka—of Northeastern University’s Health in Justice Action Lab—say the DEA “deserves much of the blame” for rising opioid-related deaths. This summer, the Centers for Disease Control and Prevention (CDC) estimated that more than 72,000 Americans died of a drug overdose in 2017—with opioids accounting for more than 49,000 of the deaths. 

    The federal agency’s response to rising opioid abuse in the United States did little to mitigate the growing epidemic, the authors write. While the DEA has the authority to establish “non-enforcement programs aimed at reducing the availability” of illicit drugs—e.g. expanding evidence-based treatment from a public health perspective—instead, in its decades-long existence, the agency has opted to ramp up the enforcement side of its mandate.

    “Instead the agency pushed for surveillance of prescription records and electronic communication, doubled down on prosecuting prescribers and helped to tighten the screws on patients seeking pain relief,” reads the op-ed.

    The agency’s enforcement-heavy response to painkiller abuse only pushed people to seek illicit substitutes like heroin and counterfeit pills, and to encourage drug traffickers to “create more compact, potent drugs” like fentanyl.

    This resulted in more deaths as well as the spread of HIV and hepatitis (from sharing needles), while access to evidence-based treatment for drug use disorder, like methadone, saw little improvement.

    Not only is the DEA accused of employing tactics that have “fueled the opioid crisis,” in the 40-plus years since it was established under the administration of former President Richard Nixon (the man who declared drugs “Public Enemy Number 1”) the agency’s approach has had a harmful effect on community policing, and it has earned a reputation for botched operations at home and abroad in its tireless campaign to hunt down illicit drug suppliers. (The agency has the largest foreign presence of any U.S. federal law enforcement agency, according to its 2018 Budget Request.)

    “It has eroded civil liberties through the expansion of warrantless surveillance, and overseen arbitrary seizures of billions of dollars of private property without any clear connection to drug-related crimes,” write Beletsky and Goulka.

    And in the DEA’s long history, “these actions have disproportionately targeted people of color, contributing to disparities in mass incarceration, confiscated property, and collective trauma.”

    By taking Nixon’s “War on Drugs” a bit too literally, the DEA’s focus on the law enforcement side of its mandate has done nothing to reduce the amount of drugs consumed by Americans. “The agency was supposed to curb problematic drug use, but failed to do so because its tactics were never informed by public health or addiction science,” write Beletsky and Goulka.

    The authors of the op-ed offer a solution: reinvent the DEA “from the bottom up.” One way to do this is to transfer regulatory authority over the pharmaceutical supply to the Food and Drug Administration.

    Currently the DEA is in charge of how controlled substances are classified, produced and distributed. (For example, under the DEA, marijuana is classified as a Schedule I drug, which are considered the most dangerous, alongside heroin and LSD.)

    Some of its law enforcement efforts can be transferred to the FBI or local authorities, or eliminated altogether, the authors suggest.

    And a “significant portion” of the DEA’s budget should go to life-saving measures like access to high-quality treatment. The agency requested a budget of $2.16 billion for fiscal year 2018, a $77 million increase from the year prior.

    According to the authors, the agency is an emblem of the failure of Nixon’s “War on Drugs” and the failure of the federal government to make significant progress in reducing drug abuse in the United States.

    Forty-seven years after Nixon declared a “War on Drugs,” the authors say it’s time to “urgently rethink how our nation regulates drugs.”

    View the original article at thefix.com

  • Pain Patients Rally To Have Voices Heard

    Pain Patients Rally To Have Voices Heard

    “The real message is that people in chronic pain are not drug abusers. Illicit drug use is the enemy,” said one rally participant. 

    People suffering from chronic pain gathered earlier this week in New Hampshire, hoping to share their frustrations about prescription opioid restrictions in one of the states hardest hit by the opioid epidemic. 

    “The pendulum has swung so far that now, people who have legitimate, documented, disease and illness and pain are now having their medications limited,” Bill Murphy, who helped organize the rally, told WMUR.

    Similar Don’t Punish Pain rallies were held in about 80 locations around the country. Participants say that they need pain medications—including opioids—to manage their chronic conditions. They say that long-term use of opioids can vastly improve the lives of people suffering from chronic pain, but that opioid painkillers have become misunderstood and stigmatized because of widespread misuse. 

    “Chronic pain patients are being denied their medications due to a false narrative that the drug epidemic is caused by prescription pain pills,” Kim Patty, who helped organize a rally in Springfield, Missouri, told the Springfield News-Leader. “The drug epidemic is being caused by heroin and synthetic fentanyl.”

    Participants in New Hampshire said this message gets lost. “It’s important for pain patients to have respect,” said Edie Allyn-Paige, who lives with chronic pain. “You know, every day, I have to choose whether or not to get out of bed.” 

    Bobbi Blades has had chronic pain for 30 years caused by a bone that presses on a nerve. She said that without opioids she wouldn’t have been able to complete rehabilitation, which helped her regain the ability to walk. “The real message is that people in chronic pain are not drug abusers,” she said. “Illicit drug use is the enemy.”

    Murphy said that unlike many people who abuse opioids, responsible users take low doses and are functional at home and at work. Despite that, many people have had their doctors cut back on their pain medications under pressure to reduce prescribing. “Because of that low-dose regimen, (people) are still working, raising families, and their doctors are feeling pressured to reduce that pain medication,” he said.

    Cheryl Ostrander, who rallied in Springfield, said she has used painkillers to help her cope with breast cancer, knee replacements, spinal fusions and fibromyalgia.

    “I am struggling really hard just to stay here,” Ostrander said. “I am in pain just like every day of my life. I’m a mess, but I don’t deserve to be treated like a criminal to get my pain medication.”

    View the original article at thefix.com

  • Science Series NOVA Tackles US Drug Crisis in PBS' "Addiction"

    Science Series NOVA Tackles US Drug Crisis in PBS' "Addiction"

    The PBS documentary airs on October 19th.

    The opioid crisis affects entire communities across the United States—yet there is still much about opioid abuse that is poorly understood.

    A new documentary airing on PBS aims to change that by exploring the crisis from different angles.

    ADDICTION, produced by NOVA, tackles both the science of addiction and the real impact that it’s had on Americans.

    “Nearly every family in America has been affected by addiction—the biggest public health crisis facing us today—yet it remains poorly understood, largely stigmatized, and finding treatment can be a daunting process,” said Paula S. Apsell, Senior Executive Producer of NOVA. “NOVA helps cut through the confusion by presenting the latest science on what we now know is a treatable brain disorder, and not a hopeless diagnosis.”

    The documentary explores harm reduction programs across North America and the impact they’ve had—from Insite in Vancouver, Canada (the first supervised injection facility in North America) to West Virginia, which has adopted a harm reduction approach to the drug problem there.

    Under West Virginia’s public health commissioner Rahul Gupta, who will step down from his post in November, the state dispatched a free mobile unit and volunteer medical team to offer a host of harm reduction services including needle exchange, HIV and hepatitis testing, and free naloxone, (the anti-opioid overdose medication).

    A major benefit to investing in a harm reduction approach is financial. Gupta says that with every $1 spent on harm reduction, we save $7 in medical costs, in addition to being able to guide people toward treatment.

    “The costs are really unsustainable if we continue on this path, losing over half a trillion dollars a year for multiple years in our economy. We’ve got to be smart about addressing addiction,” said Gupta. “We have to find ways to prevent it from happening in the first place.”

    Dr. Laura Kehoe oversees a unique program at Massachusetts General Hospital in Boston that offers medication to overdose survivors to control cravings.

    “We’re seeing people come that day and engage in care, and the vast majority of them, 75 to 80% are returning,” she said. “Tragically, evidence-based treatments are not widely available in the U.S., and patients and families have to navigate a very broken system of care.”

    View the original article at thefix.com

  • Meth Use Rises Among Youth, Heroin Use Declines

    Meth Use Rises Among Youth, Heroin Use Declines

    The results of a new survey from Substance Abuse and Mental Health Administration revealed some positive movement for the opioid crisis.

    In another reminder of how complicated addiction and addiction treatment is, compiled survey results from 67,500 Americans in 2017 found that while new heroin users in certain age groups have almost declined by half, methamphetamine and marijuana use has increased.

    The survey, conducted by the Substance Abuse and Mental Health Administration, (SAMHSA) parsed survey takers by age groups, types of drugs used, amounts of drugs used, and the starting point for the usage or abuse of each drug.

    The most dramatic, positive findings were around new heroin users; 81,000 reported using heroin for the first time in 2017, less than half of the 170,000 reported the year before.

    However, when looking at the age group of 18-25, the decline in new heroin users was “almost imperceptible” according to USA Today

    The 18 to 25 category also reported less prescription opioid abuse. SAMHSA estimated that in 2015 8.5% of people in this vulnerable age range misused prescription opioids; In 2017 the percentage was at 7.

    Yet marijuana and meth use for youths 12-17 increased from all previous years. Marijuana use for both youth and adults was associated with opioid use, heavy alcohol use, and major depressive episodes.

    The concerning effects of heavy marijuana use on mental illness has been somewhat put to the backburner as popular culture embraces the positive aspects of the drug. Some research show a direct correlation between marijuana overuse and mental distress and illness.

    With all the publicity surrounding deaths from heroin laced with fentanyl, addiction specialist Sally Satel says most addiction experts had anticipated a move away from opioids and toward another drug.

    “I was waiting for this,” Satel told USA Today, “This is how it works. People still want to alter their mental state. So they look for what’s cheap and what’s available and the reputation of the drug.” 

    Jim Beiting, CEO of Transitions, Northern Kentucky’s largest drug treatment and recovery organization, told USA Today that meth is “magnetic” for people with addiction trying to move from opioids. “It’s cheaper,” he says. “It’s more readily available, (and) the potency is higher than it used to be.”

    Other positive news from the SAMHSA report reveals that more people struggling with heroin addiction are seeking treatment, up 53.7% from previous years. This seems to reflect on the increased funding, country-wide, into access and quality of addiction treatment services.

    The news is mixed but overall illuminates how bad the addiction crisis remains in our country. James Carrol, acting director of the Office of National Drug Control Policy, told the Washington Times, “Use of marijuana, cocaine and methamphetamine are all up. So we aren’t just in an opioids crisis. It’s an addiction crisis.”

    View the original article at thefix.com

  • Senate Passes Sweeping Opioid Legislation, Treatment Advocates Unimpressed

    Senate Passes Sweeping Opioid Legislation, Treatment Advocates Unimpressed

    “None of the bills include providing the one thing communities hit by the opioid crisis need most: funding,” says one treatment advocate.

    A bipartisan effort to stem the opioid crisis, while impressive in scope, does not have what it takes to stem the national opioid crisis, say treatment advocates.

    On Monday (Sept. 17), the Senate passed a package of 70 bills—racking up a cost of $8.4 billion—with a 99-to-1 vote to address various aspects of the opioid crisis. The lone dissenter was Senator Mike Lee of Utah.

    The goal was to tackle the opioid crisis from multiple angles—like expanding access to treatment and thwarting shipments of illicit drugs from abroad—but not everyone is impressed with the expansive legislation.

    Joy Burwell, president and CEO of the National Council for Behavioral Health, which represents American health care organizations that deliver mental health and substance use disorder services, expressed her organization’s disappointment that “Congress missed this opportunity to make a meaningful, long-term investment in our nation’s addiction treatment system.”

    One way to accomplish this, Burwell says, would be to include the the Excellence in Mental Health and Addiction Treatment Expansion Act, a bill that would expand a current program that has shown success in improving access to addiction treatment services.

    The package of bills passed in the Senate, however, falls short of their expectations. “None of the bills include providing the one thing communities hit by the opioid crisis need most: funding,” wrote Burwell in a statement. “Nor do they offer a comprehensive solution to the country’s addiction crisis.”

    The legislation package includes various measures intended to fight substance abuse. They include expanding access to opioid-addiction medication (like buprenorphine); funding recovery centers that provide temporary housing, job training, and other support during a transition to recovery; expanding the scope of mental health professionals where they are in short supply; expanding first responder naloxone programs; and preventing illicit drugs from being shipped via the US Postal Service.

    Sen. Rob Portman of Ohio admitted that the legislation does have missing pieces. “It doesn’t include everything all of us want to see but it has important new initiatives and it’s a step in the right direction,” he said, according to the Washington Post. “Congress is committing itself to actually putting politics aside. It’s not just bipartisan—I think it’s nonpartisan.”

    According to the Post, the House passed a similar measure in June. Now the two chambers will go over the differences before sending the package off to Trump.

    View the original article at thefix.com

  • Roseanne Barr Says Her Character On "Conners" Will Suffer Fatal Overdose

    Roseanne Barr Says Her Character On "Conners" Will Suffer Fatal Overdose

    Barr revealed the alleged fate of her namesake character in a recent interview.

    As the premiere of The Conners nears, fans of the show are that much closer to learning how Roseanne Conner gets written off the show.

    In May, Roseanne Barr was kicked off her own classic sitcom, Roseanne, over a racist tweet that ABC Entertainment President Channing Dungey called “abhorrent, repugnant and inconsistent with our values.”

    The show was revived in 2018 and enjoyed positive reviews, but was canceled in May because of the controversy.

    ABC decided to move on without Barr with its spin-off The Conners, which airs on October 16.

    John Goodman, who plays Roseanne’s husband Dan Conner, hinted at Roseanne’s death in a recent interview with The Times. “I guess [Dan will] be mopey and sad because his wife’s dead,” he said in August.

    While we won’t know Roseanne’s fate until the show airs, Barr said in a new interview that her character dies of a drug overdose. “Oh ya, they killed her. They have her die of an opioid overdose,” she said on the YouTube show Walk Away.

    She’s not happy about it. “It wasn’t enough to [fire me], they had to so cruelly insult the people who loved that family and that show,” she said.

    But the comedian, who was also dropped by her talent agency at the peak of the controversy, is ready to move on from the drama. “There’s nothing I can do about it. It’s done. It’s over. There’s no fight left.”

    According to People, The Conners officially started production in August. The spin-off will follow “the Conner family who, after a sudden turn of events, are forced to face the daily struggles of life in Lanford in a way they never have before.”

    While it’s a rather shocking way to write off the beloved titular character, a drug overdose is plausible for Roseanne after what we saw in the last season. 

    We learn in season 10 that Roseanne is dependent on pain medication. Desperate to put off a costly surgical procedure, she keeps secret stashes around the house to keep her pain at bay. “I got these pills because I’m going to be dealing with this for a long time,” she tells Dan in the episode “Netflix & Pill.”

    “I’m in pain so I take a few extra pills. It’s not like I’m a drug addict.”

    View the original article at thefix.com

  • Doctors Will Be Required To Check Prescription Database In California

    Doctors Will Be Required To Check Prescription Database In California

    The state’s monitoring system has been historically underused by healthcare providers. 

    Beginning on October 2, doctors in California will be required to check the state’s prescription monitoring database before writing a new prescription, in an attempt to provide better care and correct years of underutilization of the system.

    “California created the first system to track prescriptions of the strongest painkillers, but our state fell behind as the opioid crisis grew,” state Sen. Ricardo Lara, who drafted the legislation in 2015, told the Los Angeles Times. “I wrote SB 482 to require that doctors and others consult the CURES system before prescribing these powerful and addictive drugs. This tool will help limit doctor shopping, break the cycle of addiction and prevent prescriptions from ever again fueling an epidemic that claims thousands of lives.”

    California’s monitoring system, called The Controlled Substance Utilization Review and Evaluation System, or CURES, provides a list of patients’ prescriptions, the doctors who prescribed the medication and the pharmacies that filled them. The system was overhauled in 2016 to make it easier for doctors to use, and the new legislation will now require them to do so.

    Under the law, healthcare providers will need to check CURES every time they write a new prescription, or every four months for patients who have an ongoing prescription. There are exceptions, including for emergency room care and hospice patients.

    The legislation is meant to cut back on so-called doctor shopping, as well as ensure that doctors and patients are aware of any risky combinations of medicines that a patient is taking.

    “I think people make the mistake of thinking it’s just for doctor shopping,” said Dr. Roneet Lev, chief of emergency medicine at Scripps Mercy Hospital in San Diego. “Using CURES just makes you a smarter, better doctor.”

    Although some doctors balk at the amount of time that it will take to consult CURES, other believe that using the system will soon become second nature.

    “I think it’s going to be one of those things that a year from now is going to be second [nature] to them,” said Kimberly Kirchmeyer, executive director of the Medical Board of California. “It’s just the first round of it gets hard for them. Any additional administrative task for physicians in the world they live in is difficult for them, and we completely understand that.”

    However, if the requirement helps to protect patients, doctors say that they are willing to spend time using the CURES system.

    “I think every doctor in California will gladly do it as long as there’s a pot of gold at the end of the rainbow,” said Dr. Jason Toranto, chief of plastic surgery at Senta Clinic in San Diego. “As long as the patient is going to do better, that’s what it’s all about.”

    View the original article at thefix.com